{
  "docId": "019de076-213d-70dd-a534-653b847b5e3f",
  "docSlug": "a748211b037be53bd983a1c4e3bfc311",
  "documentTitle": "argenx SE | Investor Presentation Deck | 7 slides",
  "authorId": "argenx-se",
  "authorName": "argenx",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 3,
  "pageCount": 7,
  "prevPage": 2,
  "nextPage": 4,
  "slideType": "key_takeaways",
  "function": "summarize",
  "density": "balanced",
  "nDataPoints": 4,
  "notes": "The slide uses a clear contrast between the failed primary endpoint and the positive safety/PD profile to frame the conclusion.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-213d-70dd-a534-653b847b5e3f/3",
  "deckHref": "/decks/019de076-213d-70dd-a534-653b847b5e3f",
  "deckJsonHref": "/decks/019de076-213d-70dd-a534-653b847b5e3f.json",
  "deckAnchorHref": "/decks/019de076-213d-70dd-a534-653b847b5e3f#slide-3",
  "components": [
    {
      "bbox": {
        "h": 0.08,
        "w": 0.86,
        "x": 0.07,
        "y": 0.81
      },
      "kind": "callout",
      "text": "Disease pathology in a refractory ITP patient population is more complex",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4cade71d-cefd-4f45-bcc0-b86566452cc5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.46,
        "x": 0.51,
        "y": 0.18
      },
      "kind": "list",
      "text": "Efficacy: Study did not meet primary or secondary endpoints. Safety: Well-tolerated and consistent with confirmed safety profile of VYVGART and VYVGART Hytrulo. PD Effect: Treated patients achieved same magnitude of total IgG reduction as seen in previous clinical trials",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "85977726-3ca2-4ec7-aa2b-909e98738bbe",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.4,
        "x": 0.03,
        "y": 0.175
      },
      "kind": "table",
      "text": "Primary Endpoint Analysis: Treated 13.7% (17/124), Placebo 16.2% (11/68)",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b5f217d0-529f-4243-883e-540eb15c9ae4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.4,
        "x": 0.03,
        "y": 0.06
      },
      "kind": "title",
      "text": "ADVANCE-SC Study Conclusions",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3a78604f-c061-4ea4-b358-a81e6d84c86c",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Table data",
      "slug": "table-data",
      "agent": null,
      "layer": "slide",
      "matchId": "a3d994cb-84e1-485f-9408-9e96b0eec4b8",
      "evidence": "The slide includes a table with data.",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 3,
      "from": 3,
      "beatId": "4e0852d8-988a-41ad-8e0d-985873492ee8",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Problem",
      "beatSlug": "sequoia-pitch-problem",
      "evidence": "disease pathology complexity",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 7,
      "from": 3,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "87b7f924-5d07-4995-9c4d-f983349403a3",
      "evidence": "emphasis on transforming severe autoimmunity",
      "position": 0,
      "objective": "Highlighting the need for innovative treatments",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}